 | • レポートコード：MRC2012A2866 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、直接的レニン阻害薬（DRI）の世界市場を広く調査・分析し、今後の市場展望をまとめております。直接的レニン阻害薬（DRI）の種類別市場規模（アリスキレン、レミキレン、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Noden Pharma、LGM Pharma、Cayman、 ・地域別グローバル市場分析 2015年-2020年 ・直接的レニン阻害薬（DRI）の北米市場（アメリカ、カナダ、メキシコ） ・直接的レニン阻害薬（DRI）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・直接的レニン阻害薬（DRI）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・直接的レニン阻害薬（DRI）の南米市場（ブラジル、アルゼンチン） ・直接的レニン阻害薬（DRI）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アリスキレン、レミキレン、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Direct Renin Inhibitors (DRIs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Direct Renin Inhibitors (DRIs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Direct Renin Inhibitors (DRIs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Direct Renin Inhibitors (DRIs) market has been segmented into
Aliskiren
Remikiren
Others
By Application, Direct Renin Inhibitors (DRIs) has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Direct Renin Inhibitors (DRIs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Direct Renin Inhibitors (DRIs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Direct Renin Inhibitors (DRIs) market.
The report offers in-depth assessment of the growth and other aspects of the Direct Renin Inhibitors (DRIs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Direct Renin Inhibitors (DRIs) Market Share Analysis
Direct Renin Inhibitors (DRIs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Direct Renin Inhibitors (DRIs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Direct Renin Inhibitors (DRIs) sales, revenue and market share for each player covered in this report.
The major players covered in Direct Renin Inhibitors (DRIs) are:
Noden Pharma
LGM Pharma
Cayman
Among other players domestic and global, Direct Renin Inhibitors (DRIs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Direct Renin Inhibitors (DRIs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Direct Renin Inhibitors (DRIs), with price, sales, revenue and global market share of Direct Renin Inhibitors (DRIs) in 2018 and 2019.
Chapter 3, the Direct Renin Inhibitors (DRIs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Direct Renin Inhibitors (DRIs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Direct Renin Inhibitors (DRIs) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Direct Renin Inhibitors (DRIs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Direct Renin Inhibitors (DRIs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Direct Renin Inhibitors (DRIs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Aliskiren
1.2.3 Remikiren
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Direct Renin Inhibitors (DRIs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Direct Renin Inhibitors (DRIs) Market
1.4.1 Global Direct Renin Inhibitors (DRIs) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Noden Pharma
2.1.1 Noden Pharma Details
2.1.2 Noden Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Noden Pharma SWOT Analysis
2.1.4 Noden Pharma Product and Services
2.1.5 Noden Pharma Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 LGM Pharma
2.2.1 LGM Pharma Details
2.2.2 LGM Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 LGM Pharma SWOT Analysis
2.2.4 LGM Pharma Product and Services
2.2.5 LGM Pharma Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cayman
2.3.1 Cayman Details
2.3.2 Cayman Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cayman SWOT Analysis
2.3.4 Cayman Product and Services
2.3.5 Cayman Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Direct Renin Inhibitors (DRIs) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Direct Renin Inhibitors (DRIs) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Direct Renin Inhibitors (DRIs) Manufacturer Market Share in 2019
3.3.2 Top 6 Direct Renin Inhibitors (DRIs) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Regions
4.1.1 Global Direct Renin Inhibitors (DRIs) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Direct Renin Inhibitors (DRIs) Revenue and Market Share by Regions (2015-2020)
4.2 North America Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
4.3 Europe Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
4.5 South America Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Country
5.1.1 North America Direct Renin Inhibitors (DRIs) Sales and Market Share by Country (2015-2020)
5.1.2 North America Direct Renin Inhibitors (DRIs) Revenue and Market Share by Country (2015-2020)
5.2 United States Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
5.3 Canada Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
5.4 Mexico Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Country
6.1.1 Europe Direct Renin Inhibitors (DRIs) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Direct Renin Inhibitors (DRIs) Revenue and Market Share by Country (2015-2020)
6.2 Germany Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
6.3 UK Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
6.4 France Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
6.5 Russia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
6.6 Italy Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Direct Renin Inhibitors (DRIs) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Direct Renin Inhibitors (DRIs) Revenue and Market Share by Regions (2015-2020)
7.2 China Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7.3 Japan Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7.4 Korea Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7.5 India Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
7.7 Australia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Country
8.1.1 South America Direct Renin Inhibitors (DRIs) Sales and Market Share by Country (2015-2020)
8.1.2 South America Direct Renin Inhibitors (DRIs) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
8.3 Argentina Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Direct Renin Inhibitors (DRIs) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Direct Renin Inhibitors (DRIs) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Direct Renin Inhibitors (DRIs) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
9.3 Turkey Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
9.4 Egypt Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
9.5 South Africa Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Direct Renin Inhibitors (DRIs) Sales and Market Share by Type (2015-2020)
10.2 Global Direct Renin Inhibitors (DRIs) Revenue and Market Share by Type (2015-2020)
10.3 Global Direct Renin Inhibitors (DRIs) Price by Type (2015-2020)
11 Global Direct Renin Inhibitors (DRIs) Market Segment by Application
11.1 Global Direct Renin Inhibitors (DRIs) Sales Market Share by Application (2015-2020)
11.2 Global Direct Renin Inhibitors (DRIs) Revenue Market Share by Application (2015-2020)
11.3 Global Direct Renin Inhibitors (DRIs) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Direct Renin Inhibitors (DRIs) Sales, Revenue and Growth Rate (2021-2025)
12.2 Direct Renin Inhibitors (DRIs) Market Forecast by Regions (2021-2025)
12.2.1 North America Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025)
12.2.2 Europe Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025)
12.2.4 South America Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025)
12.3 Direct Renin Inhibitors (DRIs) Market Forecast by Type (2021-2025)
12.3.1 Global Direct Renin Inhibitors (DRIs) Sales Forecast by Type (2021-2025)
12.3.2 Global Direct Renin Inhibitors (DRIs) Market Share Forecast by Type (2021-2025)
12.4 Direct Renin Inhibitors (DRIs) Market Forecast by Application (2021-2025)
12.4.1 Global Direct Renin Inhibitors (DRIs) Sales Forecast by Application (2021-2025)
12.4.2 Global Direct Renin Inhibitors (DRIs) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Direct Renin Inhibitors (DRIs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Direct Renin Inhibitors (DRIs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Direct Renin Inhibitors (DRIs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Noden Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Noden Pharma Direct Renin Inhibitors (DRIs) Major Business
Table 9. Noden Pharma Direct Renin Inhibitors (DRIs) Total Revenue (USD Million) (2017-2018)
Table 10. Noden Pharma SWOT Analysis
Table 11. Noden Pharma Direct Renin Inhibitors (DRIs) Product and Services
Table 12. Noden Pharma Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. LGM Pharma Basic Information, Manufacturing Base and Competitors
Table 14. LGM Pharma Direct Renin Inhibitors (DRIs) Major Business
Table 15. LGM Pharma Direct Renin Inhibitors (DRIs) Total Revenue (USD Million) (2017-2018)
Table 16. LGM Pharma SWOT Analysis
Table 17. LGM Pharma Direct Renin Inhibitors (DRIs) Product and Services
Table 18. LGM Pharma Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cayman Basic Information, Manufacturing Base and Competitors
Table 20. Cayman Direct Renin Inhibitors (DRIs) Major Business
Table 21. Cayman Direct Renin Inhibitors (DRIs) Total Revenue (USD Million) (2017-2018)
Table 22. Cayman SWOT Analysis
Table 23. Cayman Direct Renin Inhibitors (DRIs) Product and Services
Table 24. Cayman Direct Renin Inhibitors (DRIs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Direct Renin Inhibitors (DRIs) Sales by Manufacturer (2018-2019) (K MT)
Table 26. Global Direct Renin Inhibitors (DRIs) Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Direct Renin Inhibitors (DRIs) Sales by Regions (2015-2020) (K MT)
Table 28. Global Direct Renin Inhibitors (DRIs) Sales Market Share by Regions (2015-2020)
Table 29. Global Direct Renin Inhibitors (DRIs) Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Direct Renin Inhibitors (DRIs) Sales by Countries (2015-2020) (K MT)
Table 31. North America Direct Renin Inhibitors (DRIs) Sales Market Share by Countries (2015-2020)
Table 32. North America Direct Renin Inhibitors (DRIs) Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020)
Table 34. Europe Direct Renin Inhibitors (DRIs) Sales by Countries (2015-2020) (K MT)
Table 35. Europe Direct Renin Inhibitors (DRIs) Sales Market Share by Countries (2015-2020)
Table 36. Europe Direct Renin Inhibitors (DRIs) Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Direct Renin Inhibitors (DRIs) Sales by Regions (2015-2020) (K MT)
Table 38. Asia-Pacific Direct Renin Inhibitors (DRIs) Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Direct Renin Inhibitors (DRIs) Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Direct Renin Inhibitors (DRIs) Sales by Countries (2015-2020) (K MT)
Table 41. South America Direct Renin Inhibitors (DRIs) Sales Market Share by Countries (2015-2020)
Table 42. South America Direct Renin Inhibitors (DRIs) Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Direct Renin Inhibitors (DRIs) Sales by Countries (2015-2020) (K MT)
Table 45. Middle East & Africa Direct Renin Inhibitors (DRIs) Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Direct Renin Inhibitors (DRIs) Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020)
Table 48. Global Direct Renin Inhibitors (DRIs) Sales by Type (2015-2020) (K MT)
Table 49. Global Direct Renin Inhibitors (DRIs) Sales Share by Type (2015-2020)
Table 50. Global Direct Renin Inhibitors (DRIs) Revenue by Type (2015-2020) (USD Million)
Table 51. Global Direct Renin Inhibitors (DRIs) Revenue Share by Type (2015-2020)
Table 52. Global Direct Renin Inhibitors (DRIs) Sales by Application (2015-2020) (K MT)
Table 53. Global Direct Renin Inhibitors (DRIs) Sales Share by Application (2015-2020)
Table 54. Global Direct Renin Inhibitors (DRIs) Sales Forecast by Regions (2021-2025) (K MT)
Table 55. Global Direct Renin Inhibitors (DRIs) Market Share Forecast by Regions (2021-2025)
Table 56. Global Direct Renin Inhibitors (DRIs) Sales Forecast by Type (2021-2025) (K MT)
Table 57. Global Direct Renin Inhibitors (DRIs) Market Share Forecast by Type (2021-2025)
Table 58. Global Direct Renin Inhibitors (DRIs) Sales Forecast by Application (2021-2025)
Table 59. Global Direct Renin Inhibitors (DRIs) Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Direct Renin Inhibitors (DRIs) Picture
Figure 2. Global Sales Market Share of Direct Renin Inhibitors (DRIs) by Type in 2019
Figure 3. Aliskiren Picture
Figure 4. Remikiren Picture
Figure 5. Others Picture
Figure 6. Direct Renin Inhibitors (DRIs) Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global Direct Renin Inhibitors (DRIs) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Direct Renin Inhibitors (DRIs) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Direct Renin Inhibitors (DRIs) Sales Market Share by Manufacturer in 2019
Figure 31. Global Direct Renin Inhibitors (DRIs) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Direct Renin Inhibitors (DRIs) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Direct Renin Inhibitors (DRIs) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Direct Renin Inhibitors (DRIs) Revenue Market Share by Regions (2015-2020)
Figure 38. Global Direct Renin Inhibitors (DRIs) Revenue Market Share by Regions in 2018
Figure 39. North America Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
Figure 40. Europe Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
Figure 42. South America Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020)
Figure 44. North America Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Direct Renin Inhibitors (DRIs) Sales Market Share by Countries (2015-2020)
Figure 46. North America Direct Renin Inhibitors (DRIs) Sales Market Share by Countries in 2018
Figure 47. North America Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries in 2018
Figure 49. United States Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries in 2019
Figure 55. Germany Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Direct Renin Inhibitors (DRIs) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Direct Renin Inhibitors (DRIs) Revenue Market Share by Regions 2019
Figure 63. China Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Direct Renin Inhibitors (DRIs) Sales Market Share by Countries in 2019
Figure 70. South America Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries in 2019
Figure 71. Brazil Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Direct Renin Inhibitors (DRIs) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Direct Renin Inhibitors (DRIs) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Direct Renin Inhibitors (DRIs) Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Direct Renin Inhibitors (DRIs) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Direct Renin Inhibitors (DRIs) Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
TNF阻害剤の世界市場（～2026年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…- シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- DPP IV阻害剤（DPP-4阻害剤）の世界市場（～2026年） DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of in…
- 癌治療用チェックポイント阻害剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Checkpoint Inhibitors for Treating Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- プロテアソーム阻害剤の世界市場（～2026年） Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. Proteasome inhibitors are being studied in the treatment of cancer and are used in treating multiple myeloma. Market Analysis and Insights: Global Proteasome Inhibitors Market The globa…